NEA

Co-founder of Generative AI Company Persado to Speak at Shoptalk 2024

Retrieved on: 
Lunedì, Febbraio 26, 2024

Assaf Baciu , Co-founder and President at Persado , will speak at Shoptalk 2024 in Las Vegas .

Key Points: 
  • Assaf Baciu , Co-founder and President at Persado , will speak at Shoptalk 2024 in Las Vegas .
  • Attendees will hear insights about how to leverage innovations––such as generative AI––to optimize marketing strategies, campaigns, and messages, driving revenue.
  • Assaf and a team of GenAI for marketing experts will also be available at the Persado Shoptalk booth (#504) to discuss Persado’s Motivation AI solutions .
  • Session is 8:30 – 9:10 am on Tuesday, March 19, 2024
    The Persado booth will be open during Show Expo hours.

Biggs Museum of American Art to Receive $10,000 Grant from the National Endowment for the Arts

Retrieved on: 
Mercoledì, Marzo 6, 2024

DOVER, Del., March 6, 2024 /PRNewswire/ -- Biggs Museum of American Art is pleased to announce it has been approved by the National Endowment for the Arts (NEA) for a Challenge America award of $10,000.

Key Points: 
  • DOVER, Del., March 6, 2024 /PRNewswire/ -- Biggs Museum of American Art is pleased to announce it has been approved by the National Endowment for the Arts (NEA) for a Challenge America award of $10,000.
  • This grant will support the development and facilitation of Spanish language family programming within the museum.
  • "The NEA is delighted to announce this grant to the Biggs Museum of American Art, which is helping contribute to the strength and well-being of the arts sector and local community," said National Endowment for the Arts Chair Maria Rosario Jackson, PhD.
  • The program will fund family-oriented, Spanish language art programming, including gallery tours, art making workshops, and programs to engage students in cross-disciplinary art centric activities.

Appier closes out its financial year with all-time revenue and profitability highs

Retrieved on: 
Mercoledì, Febbraio 14, 2024

Appier closed out the fiscal year of 2023 with all-time revenue highs of 26.4 billion yen and a 36% YoY growth rate.

Key Points: 
  • Appier closed out the fiscal year of 2023 with all-time revenue highs of 26.4 billion yen and a 36% YoY growth rate.
  • Furthermore, Appier reported a 37% YoY increase in gross profit, outpacing its revenue growth, a testament to continuous gross margin improvement.
  • In geographical terms, significant revenue came from the US and EMEA (16%), which saw an 84% YoY growth.
  • Appier concluded the year on a high note, with Q4 showcasing a remarkable 32% YoY revenue growth, culminating in an unprecedented quarterly revenue of 7.6 billion yen.

Appier Closes Out Its Financial Year with All-Time Revenue and Profitability Highs

Retrieved on: 
Mercoledì, Febbraio 14, 2024

Strong business momentum supports an optimistic outlook for 2024

Key Points: 
  • Appier closed out the fiscal year of 2023 with all-time revenue highs of 26.4 billion yen and a 36% YoY growth rate.
  • Furthermore, Appier reported a 37% YoY increase in gross profit, outpacing its revenue growth, a testament to continuous gross margin improvement.
  • In geographical terms, significant revenue came from the US and EMEA (16%), which saw an 84% YoY growth.
  • Appier concluded the year on a high note, with Q4 showcasing a remarkable 32% YoY revenue growth, culminating in an unprecedented quarterly revenue of 7.6 billion yen.

Vyne Dental Provides Award-Winning Customer Service in 2023

Retrieved on: 
Martedì, Febbraio 6, 2024

INDIANAPOLIS, Feb. 6, 2024 /PRNewswire-PRWeb/ -- Vyne Dental, a leading provider of dental practice revenue acceleration solutions, proudly announces its exceptional 2023 customer service achievements culminating in an impressive 4.9 rating on Google in addition to winning The LiveHelpNow Challenge Best Customer Service award.

Key Points: 
  • Sets the Standard for Outstanding Support, Achieving a Remarkable 4.9 Google Rating and LiveHelpNow Customer Service Award for 2023
    INDIANAPOLIS, Feb. 6, 2024 /PRNewswire-PRWeb/ -- Vyne Dental, a leading provider of dental practice revenue acceleration solutions , proudly announces its exceptional 2023 customer service achievements culminating in an impressive 4.9 rating on Google in addition to winning The LiveHelpNow Challenge Best Customer Service award.
  • LiveHelpNow has also announced that Vyne Dental (aka NEA) made The LiveHelpNow Challenge list of top companies providing exceptional customer service in the month of December, measured by LiveHelpNow's customer service metric score.
  • Key Highlights of Vyne Dental's® Customer Service Excellence in 2023:
    Responsive Support Team: Our customer service team has been consistently responsive, ensuring that customer queries and concerns are addressed promptly and effectively.
  • Vyne Dental looks forward to 2024 with enthusiasm, continuing to set the standard for excellence in customer service within the dental practice management industry.

Metronome, Leading Provider of Usage-based Billing, Raises $43M to Reimagine Billing for SaaS

Retrieved on: 
Mercoledì, Gennaio 31, 2024

Metronome, the leading provider of usage-based billing for companies including OpenAI, Databricks, and NVIDIA, today announced the close of its $43 million Series B funding round to reimagine billing for SaaS companies.

Key Points: 
  • Metronome, the leading provider of usage-based billing for companies including OpenAI, Databricks, and NVIDIA, today announced the close of its $43 million Series B funding round to reimagine billing for SaaS companies.
  • The round was led by NEA, with strong participation from prior backers Andreessen Horowitz and General Catalyst.
  • In conjunction with the funding, Hilarie Koplow-McAdams , Venture Partner at NEA, joined the company’s board of directors.
  • The company has seen significant momentum, growing revenue 6x over the last year and powering billing for millions of end-customers.

New York Women in Film & Television Announces Science in Motion Screening Series in Partnership with BAM

Retrieved on: 
Martedì, Gennaio 30, 2024

The six-week free series features STEM-focused narrative and documentary films with filmmaker Q&A's

Key Points: 
  • New York, New York--(Newsfile Corp. - January 29, 2024) - New York Women in Film & Television (NYWIFT) is proud to present the Science in Motion Screening Series in partnership with BAM (Brooklyn Academy of Music), a collection of groundbreaking contemporary films that delve into science and technology in the modern world.
  • The program is free and open to the public, presented in partnership with the National Science Foundation (NSF) with support from the National Endowment for the Arts (NEA).
  • "Since early childhood I have been fascinated by the intersection of STEM and the media, exploring how film can expose us to all of the innovations science has to offer.
  • "BAM is thrilled to partner with NYWIFT to spotlight these extraordinary and groundbreaking films.

ORIC Pharmaceuticals Announces $125 Million Private Placement Financing

Retrieved on: 
Lunedì, Gennaio 22, 2024

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Jan. 22, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that it has agreed to sell approximately 12.5 million shares of its common stock to a select group of institutional and accredited healthcare specialist investors in a private placement, at a price per share of $10.00, representing a premium of approximately 10% to ORIC’s 5-day trailing average price. The financing is expected to close on January 23, 2024, subject to customary closing conditions. ORIC anticipates the gross proceeds from the private placement to be approximately $125 million, before deducting any offering related expenses.

Key Points: 
  • The financing is expected to close on January 23, 2024, subject to customary closing conditions.
  • ORIC anticipates the gross proceeds from the private placement to be approximately $125 million, before deducting any offering related expenses.
  • The financing includes participation from new and existing institutional investors, including Viking Global Investors, Commodore Capital, Frazier Life Sciences, Venrock Healthcare Capital Partners, NEA, and Nextech1.
  • ORIC has agreed to file a registration statement with the U.S. Securities and Exchange Commission (the “SEC”) registering the resale of the shares of common stock issued in this private placement.

Summa Health and General Catalyst’s HATCo announce plans for acquisition that will transform the future of healthcare

Retrieved on: 
Mercoledì, Gennaio 17, 2024

Akron, Ohio-based Summa Health and General Catalyst’s Health Assurance Transformation Corporation (HATCo) announced today that the two organizations have signed a non-binding Letter of Intent outlining HATCo’s planned acquisition of Summa Health.

Key Points: 
  • Akron, Ohio-based Summa Health and General Catalyst’s Health Assurance Transformation Corporation (HATCo) announced today that the two organizations have signed a non-binding Letter of Intent outlining HATCo’s planned acquisition of Summa Health.
  • With HATCo, Summa Health will be able to increase local investment and introduce new resources that allow us to expand access to affordable, quality, coordinated care,” said Cliff Deveny, M.D., Summa Health President and CEO.
  • We are thrilled to partner with Summa Health to bring this vision to life,” said Marc Harrison, M.D., co-founder and CEO of HATCo.
  • I couldn’t be more excited to collaborate and execute on that vision with Summa Health and HATCo.

NEA'S SEAL OF ACCEPTANCE EXPANDS WITH TWO NEW PRODUCT CATEGORIES

Retrieved on: 
Mercoledì, Gennaio 24, 2024

NOVATO, Calif., Jan. 24, 2024 /PRNewswire/ -- The National Eczema Association today announced the expansion of its Seal of Acceptance™ program to include two new product categories that will now be eligible for the Seal: lip care and deodorant. Applications for all Seal product categories including lip care and deodorant products are currently being accepted. Eczema patients and caregivers – and those with sensitive skin – can expect to see new lip care and deodorant products awarded with the Seal in the coming months.

Key Points: 
  • NOVATO, Calif., Jan. 24, 2024 /PRNewswire/ -- The National Eczema Association today announced the expansion of its Seal of Acceptance™ program to include two new product categories that will now be eligible for the Seal: lip care and deodorant.
  • Applications for all Seal product categories including lip care and deodorant products are currently being accepted.
  • Eczema patients and caregivers – and those with sensitive skin – can expect to see new lip care and deodorant products awarded with the Seal in the coming months.
  • Current product categories include moisturizers, sunscreens, cleansers, disposable wipes, haircare products, over-the-counter drugs, household cleaning, laundry and now, lip care and deodorant.